New Synthetic Opioid Found by New York Racing Lab

The drug, AH-7921, is one of the novel psychoactive substances that continue to emerge onto the designer drug market.
Share
Favorite
Please login

No account yet? Register

ADVERTISEMENT

The Association of Racing Commissioners International (ARCI) has put all racing regulatory agencies worldwide on notice of a finding by the New York Equine Drug Testing Program of the presence of AH-7921 in post-race samples taken from horses that recently ran at Belmont Park.

This is the first time AH-7921 has been detected by a racing regulatory lab. The drug is one of the novel psychoactive substances (NPS) that continue to emerge onto the designer drug market. Research has shown that AH-7921 can be as potent as morphine, yet its core molecular structures do not resemble morphine or fentanyl which have been detected in the past by racing regulatory labs.

These NPS drugs are believed to be compounded in order to avoid detection by human testing labs.

There is no legitimate reason for AH-7921 to be present in a horse. The New York State Gaming Commission summarily suspended Thoroughbred owner/trainer Roy Sedlacek as a result of the finding

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

How do you prevent gastric ulcers in horses? Please check all that apply.
159 votes · 373 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!